Steven H. Bernstein

Steven H. Bernstein

Chief Tech/Sci/R&D Officer presso 2SEVENTY BIO, INC.

Health Technology
Consumer Services
Health Services

Profilo

Steven H.
Bernstein
is currently the Chief Medical Officer at 2seventy Bio, Inc. He previously worked as the Chairman of Immuno-Oncology Translational Research at Bristol Myers Squibb Co., a Professor of Medicine and Co-Director of Hematological at James P.
Wilmot Cancer Center, a Member of Lymphoma Working Group at SWOG, and the Chief Translational Officer at Turnstone Biologics Corp.
He received his undergraduate degree from Brandeis University and his doctorate from New York University School of Medicine.

Posizioni attive di Steven H. Bernstein

SocietàPosizioneInizio
2SEVENTY BIO, INC. Chief Tech/Sci/R&D Officer 14/02/2022
Tutte le posizioni attive di Steven H. Bernstein

Precedenti posizioni note di Steven H. Bernstein

SocietàPosizioneFine
Corporate Officer/Principal -
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal -
James P. Wilmot Cancer Center Corporate Officer/Principal -
TURNSTONE BIOLOGICS CORP. Chief Tech/Sci/R&D Officer -
Vedi nel dettaglio l'esperienza di Steven H. Bernstein

Formazione di Steven H. Bernstein

Brandeis University Undergraduate Degree
New York University School of Medicine Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Steven H. Bernstein

Relazioni

15

Relazioni di 1° grado

7

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa3
BRISTOL-MYERS SQUIBB COMPANY

Health Technology

TURNSTONE BIOLOGICS CORP.

Health Technology

2SEVENTY BIO, INC.

Health Technology

Aziende private2
James P. Wilmot Cancer Center

Health Services

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Steven H. Bernstein